Should you buy Astrana Health (ASTH)?
Updated
A healthcare services company with 56% revenue growth leadership in its peer group and a perfect four-quarter earnings beat streak, but operating margin has compressed by 11.5%, leverage stands at 33x debt-to-equity, quality falls below the minimum threshold, and only 4.3% upside remains to the analyst target — making this an unattractive setup despite the growth story.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
The business falls below the minimum quality threshold at a score of 3.6, with operating margin having compressed by 11.5% and the debt-to-equity ratio at 33 times — identified as value-trap signals — while gross margin scores near the bottom of the quality range with no identified competitive moat. Warnings | Operating margin expands above 0% for 2 consecutive quarters and the quality score rises above 4.0, clearing the minimum threshold. | →Stable |
| CounterThe cash conversion rate is exceptionally strong at 952% of net income converting to free cash flow, suggesting the business may be generating real cash even as reported margins are compressed by non-cash charges or accounting items. | ||
Management has beaten consensus estimates in all four of the last four quarters — most recently by +14%, +29%, +11%, and +21% — with an average positive surprise of approximately 18.5%, demonstrating a consistent pattern of under-promising and over-delivering. Earnings | EPS surprise exceeds 5% for each of the next 2 quarters, extending the perfect beat streak to 6 consecutive quarters. | →Stable |
| CounterWith compressed operating margins and high leverage, the underlying business is under financial pressure; the beat streak may be sustainable only as long as management can set expectations below deteriorating fundamentals, which has limits. | ||
Revenue growing at 56% year over year ranks this company as the top growth performer within its peer group, suggesting meaningful market share capture that justifies investor attention even amid quality concerns. Peer-rank breakdown | Revenue growth stays above 30% year over year for at least 2 of the next 4 quarters, confirming the growth trajectory is durable. | →Stable |
| CounterHigh leverage of 33x debt-to-equity and compressed operating margins mean growth is being financed at potentially high cost; if capital becomes more expensive or revenue growth slows, the leverage burden could become destabilizing. | ||
The business falls below the minimum quality threshold at a score of 3.6, with operating margin having compressed by 11.5% and the debt-to-equity ratio at 33 times — identified as value-trap signals — while gross margin scores near the bottom of the quality range with no identified competitive moat.
→Stable- Expectation
- Operating margin expands above 0% for 2 consecutive quarters and the quality score rises above 4.0, clearing the minimum threshold.
CounterThe cash conversion rate is exceptionally strong at 952% of net income converting to free cash flow, suggesting the business may be generating real cash even as reported margins are compressed by non-cash charges or accounting items.
Management has beaten consensus estimates in all four of the last four quarters — most recently by +14%, +29%, +11%, and +21% — with an average positive surprise of approximately 18.5%, demonstrating a consistent pattern of under-promising and over-delivering.
→Stable- Expectation
- EPS surprise exceeds 5% for each of the next 2 quarters, extending the perfect beat streak to 6 consecutive quarters.
CounterWith compressed operating margins and high leverage, the underlying business is under financial pressure; the beat streak may be sustainable only as long as management can set expectations below deteriorating fundamentals, which has limits.
Revenue growing at 56% year over year ranks this company as the top growth performer within its peer group, suggesting meaningful market share capture that justifies investor attention even amid quality concerns.
→Stable- Expectation
- Revenue growth stays above 30% year over year for at least 2 of the next 4 quarters, confirming the growth trajectory is durable.
CounterHigh leverage of 33x debt-to-equity and compressed operating margins mean growth is being financed at potentially high cost; if capital becomes more expensive or revenue growth slows, the leverage burden could become destabilizing.
▸ Show 1 more pillar▾ Show fewer
With only 4.3% headroom to the near-term analyst price target and a risk/reward ratio of 0.61-to-1 — where potential downside exceeds potential upside — the entry geometry is unattractive regardless of the underlying growth narrative.
→Stable- Expectation
- Analyst consensus price target is revised upward by more than 20%, creating meaningful headroom above the current price of $38.38.
CounterIf the perfect beat streak continues and revenue growth sustains above 30%, analysts may materially raise their targets, quickly expanding the 4.3% headroom into a compelling setup.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The business falls below the minimum quality threshold at a score of 3.6, with operating margin having compressed by 11.5% and the debt-to-equity ratio at 33 times — identified as value-trap signals — while gross margin scores near the bottom of the quality range with no identified competitive moat.
Trip ifOperating margin rises above 0% for 2 consecutive quarters and quality score rises above 4.0.
- P2Management has beaten consensus estimates in all four of the last four quarters — most recently by +14%, +29%, +11%, and +21% — with an average positive surprise of approximately 18.5%, demonstrating a consistent pattern of under-promising and over-delivering.
Trip ifEPS surprise falls below 0% for 2 consecutive quarters, breaking the perfect beat streak.
- P3Revenue growing at 56% year over year ranks this company as the top growth performer within its peer group, suggesting meaningful market share capture that justifies investor attention even amid quality concerns.
Trip ifRevenue growth falls below 30% year over year for 2 consecutive quarters.
- P4With only 4.3% headroom to the near-term analyst price target and a risk/reward ratio of 0.61-to-1 — where potential downside exceeds potential upside — the entry geometry is unattractive regardless of the underlying growth narrative.
Trip ifAnalyst consensus price target rises above $46 (more than 20% above current $38.38), creating meaningful upside headroom.
How the engine reached this verdict
TrendMatrix's engine output for Astrana Health Inc. (ASTH) is SELL_IF_HOLDING with medium conviction, score 6.1/10 at $42.46. An L1 hard-floor gate blocked the positive-verdict path — Quality below minimum threshold. Co-failing gates ( ASYMMETRY:-0.4=NEGATIVE) reinforce the read; dimensional pillars cannot lift the engine output above the verdict floor while the L1 gate is active.
The engine's exit framework anchors to a tactical sell band near $42.46, with structural invalidation at $39.31. The asymmetric R:R against a reversal hypothesis is -0.19 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bear side: V8: Target reached (-5.3% upside); Quality below floor (3.6 < 4.0); Value-trap signals (2/5): Margin compression (op margin -11.5%), High leverage (D/E 33.0). Active engine warnings: V8: Target reached (-5.3% upside), Quality below floor (3.6 < 4.0), Value-trap signals (2/5): Margin compression (op margin -11.5%), High leverage (D/E 33.0).
The dominant failed gate is reward-to-risk (NEGATIVE). SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:8.2>=5.5.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates ASTH — 10-dimension breakdown →
Bear case
- ▸V8: Target reached (-5.3% upside)
- ▸Quality below floor (3.6 < 4.0)
- ▸Value-trap signals (2/5): Margin compression (op margin -11.5%), High leverage (D/E 33.0)